| Supriya Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543434 |
NSE Symbol : SUPRIYA |
P/E(TTM) : 35.88 |
|
ISIN Demat : INE07RO01027 |
Div & Yield% : 0.11 |
EPS(TTM) : 24.69 |
|
Book Value(₹) : 148.82 |
Market Cap(₹Cr) : 7,129.17 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 86.85 | 85.44 | 76.59 | 55.53 | 58.47 |
| Net Sales | 827.87 | 696.48 | 570.34 | 460.94 | 530.05 |
| Other Income | 11.49 | 9.82 | 10.64 | 9.49 | 7.58 |
| Stock Adjustments | 11.09 | 21.26 | -30.31 | 6.51 | 3.03 |
| Total Income | 850.45 | 727.56 | 550.67 | 476.94 | 540.66 |
| EXPENDITURE : | |||||
| Raw Materials | 265.12 | 232.44 | 191.43 | 187.32 | 198.83 |
| Power and Fuel Cost | 29.77 | 24.80 | 21.37 | 20.95 | 14.07 |
| Other Manufacturing Expenses | 80.61 | 51.81 | 35.68 | 28.87 | 18.44 |
| Selling and Administration Expenses | 58.68 | 54.65 | 38.10 | 37.32 | 33.83 |
| Miscellaneous Expenses | 13.64 | 12.61 | 9.80 | 8.51 | 4.84 |
| Employee Benefit Expenses | 96.68 | 80.52 | 67.64 | 55.58 | 49.08 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 305.96 | 270.73 | 186.65 | 138.38 | 221.56 |
| Interest | 2.77 | 1.81 | 5.15 | 3.08 | 4.20 |
| Gross Profit | 303.19 | 268.92 | 181.50 | 135.30 | 217.36 |
| Depreciation | 28.41 | 20.44 | 15.81 | 11.82 | 10.12 |
| Profit Before Tax | 274.78 | 248.48 | 165.69 | 123.48 | 207.24 |
| Current Tax | 61.43 | 56.66 | 37.10 | 30.68 | 52.19 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.23 | 3.87 | 9.48 | 2.95 | 3.25 |
| Reported Net Profit | 209.12 | 187.96 | 119.11 | 89.86 | 151.81 |
| Extraordinary Items | -0.03 | 0.00 | 0.00 | -0.08 | 0.00 |
| Adjusted Net Profit | 209.15 | 187.96 | 119.11 | 89.94 | 151.81 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 781.97 | 600.45 | 486.16 | 401.13 | 253.72 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 8.05 | 6.44 | 4.83 | 4.83 | 4.39 |
| P & L Balance carried down | 983.04 | 781.97 | 600.45 | 486.16 | 401.13 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 50.00 | 50.00 | 40.00 | 30.00 | 30.00 |
| Dividend Per Share(Rs) | 1.00 | 1.00 | 0.80 | 0.60 | 0.60 |
| Earnings Per Share-Unit Curr | 25.98 | 23.35 | 14.80 | 11.16 | 18.86 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 148.81 | 123.84 | 101.31 | 86.91 | 76.50 |
| Book Value(Adj)-Unit Curr | 148.81 | 123.84 | 101.31 | 86.91 | 76.50 |
